• Corpus ID: 152789

Polycystic ovary syndrome and acne.

  title={Polycystic ovary syndrome and acne.},
  author={Sandy S. Chuan and R Jeffrey Chang},
  journal={Skin therapy letter},
  volume={15 10},
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women. It is typically characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries. Women with PCOS often experience dermatologic manifestations of hyperandrogenism, including hirsutism, acne vulgaris, and androgenic alopecia. This article will review the treatments for acne due to androgen excess in PCOS women. 

Figures from this paper

Polycystic ovary syndrome: Diagnosis and management.

Patients with PCOS may present with a combination of hyperandrogenism symptoms, menstrual irregularities, metabolic syndrome, infertility, acne, and obesity, and treatment options include oral contraceptive pills, antiandrogens, and metformin.

Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.

Polycystic Ovarian Syndrome in Female players

PCOS is quiet common gynecological disorders in recent times and has affected adversely the population and awareness regarding PCOS among females is very less and they are unaware mostly about this condition.

Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments

This manuscript focuses on summarizing the current knowledge on PCOS, underlying features, diagnosis and treatment, and identifying gaps in various aspects.


The Rotterdam criteria, introduced in 2003, is the presence of two out of three criteria for polycystic ovarian syndrome: Oligo-and/or anovulation and clinical and/ or biochemical signs of hyperandrogenism.

Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse

The aim of this study was to compare the efficacy and permanence of systemic isotretinoin in nodulocystic acne patients with and without PCOS and to evaluate the factors associated with relapse during the first and second post‐treatment years.

Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis

It may be concluded that acne is one of the common dermatological manifestations in PCOS.

Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An-Najah national university-Palestine

Prevalence of PCOS in Palestine seems to be relatively high but similar to other Mediterranean statistics, and further studies are recommended using wider age group and larger sample for all parts of Palestine in order to generalize results.

Acne in hirsute women

A high prevalence of acne was found in hirsutism and acne was higher in polycystic ovarian syndrome and since these women have associated endocrine changes it is important to correct them with hormonal therapy.

Acne Syndromes and Mosaicism

The concept of cutaneous mosaicism is summarized and elaborate on acne syndromes, as well as acneiform mosaicism, which are related to normal and abnormal mosaicism.



Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome

No uniform treatment approach for the management of the cutaneous manifestations of PCOS has been agreed upon, but the data on various treatment options and the author's treatment approach to these patients are presented.

Hirsutism and acne in polycystic ovary syndrome.

  • J. ArcherR. J. Chang
  • Medicine, Biology
    Best practice & research. Clinical obstetrics & gynaecology
  • 2004

Hormonal Therapy of Acne

  • M. Haroun
  • Medicine, Biology
    Journal of cutaneous medicine and surgery
  • 2004
Hormonal therapy is an excellent choice for female patients with acne who have SAHA syndrome, polycystic ovarian syndrome, HAIRAN syndrome, hyper androgenism, insulin resistance, acanthosis nigricans, or cutaneous hyperandrogenism and may be combined to enhance therapeutic efficacy.

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.

The results show that metformin is potentially an effective treatment for moderate to severe hirsutism in women with polycystic ovary syndrome and suggest that in some respects, it is more efficacious than the standard treatment (Dianette).

The evaluation and management of hirsutism.

  • R. Azziz
  • Medicine, Biology
    Obstetrics and gynecology
  • 2003

Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine–metabolic and ultrasonographic differences

Two different pathogenetic mechanisms may play a role in the onset of acne and hirsutism: Acne was associated only with the lowest 3α-androstanediol glucuronide levels, and the cycle alterations and the echographic ovarian morphology showed no significant differences.

The prevalence and features of the polycystic ovary syndrome in an unselected population.

Data from a large representative unselected population support the concept that PCOS is the most common endocrine abnormality of reproductive-aged women in the United States.

Correlation between endocrinological parameters and acne severity in adult women.

In post-pubertal women, severity of acne seems to depend on peripheral hyperandrogenism, with a negative relationship between the acne severity and serum SHBG levels.

Androgen Dependence of Hirsutism, Acne, and Alopecia in Women: Retrospective Analysis of 228 Patients Investigated for Hyperandrogenism

Ethinylestradiol and high-dose cyproterone acetate treatment lowered the hirsutism score to 53.5% of baseline at 1 year, and was also effective in treating acne and alopecia, and the most marked proportional decrease of all the androgens under treatment.